# Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

> **NCT05324098** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 47 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** STAND-T platform
- **OTHER:** Survey Administration
- **OTHER:** Text Messages

## Key facts

- **NCT ID:** NCT05324098
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05324098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05324098, "Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05324098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*